This compound is an antifilarial agent. Diethylcarbamazine, formulated as its citrate salt (known as Hetrazan), is used clinically for the treatment and prevention of filariasis, a disease caused by filarial worms parasitizing human lymphatic or connective tissues. Although its anthelmintic efficacy is suboptimal and it is associated with certain adverse reactions, diethylcarbamazine remains the drug of choice compared to other available antifilarial agents.